Ovarian Aging: The Hidden Clock Driving Women's Long-Term Health

What your ovaries actually do beyond fertility

Most women learn about their ovaries in the context of reproduction. What they're rarely taught is that estrogen — produced primarily by the ovaries — is one of the most systemically important hormones in the female body, with receptors in the brain, heart, bones, skin, gut, and immune system.

When ovarian function declines, every one of those systems is affected. Estrogen supports bone density by inhibiting osteoclasts (bone-breaking cells). It maintains the elasticity of arterial walls. It supports BDNF production in the brain. It stimulates collagen synthesis in skin. The reason women's cardiovascular risk, fracture risk, dementia risk, and skin aging all accelerate around menopause isn't coincidence. They share the same upstream cause: declining ovarian estrogen production.

The AMH test most women in their 30s haven't been offered

Anti-Müllerian hormone (AMH) is produced by small follicles in the ovaries and reflects ovarian reserve — how many follicles remain. Unlike FSH (which fluctuates wildly and only spikes when reserve is already critically low), AMH declines linearly and steadily from around age 25. It's the earliest measurable signal of ovarian aging.

AMH testing has historically been ordered in fertility clinics for women trying to conceive. The growing argument in longevity medicine — and the direction 2026 research is moving — is that AMH should be part of routine health monitoring from the mid-30s, regardless of fertility intentions. A low AMH at 36 isn't just a fertility data point. It's a signal that estrogen levels may decline earlier than population averages, which has implications for bone, cardiovascular, and brain health planning that aren't fertility-related at all.

What accelerates ovarian aging — and what the evidence suggests may protect it

Ovarian aging is primarily genetic — your follicle count at birth is the single biggest determinant of when you reach menopause. But several modifiable factors appear to accelerate or decelerate the process, based on current evidence.

Smoking is the most clearly documented accelerant: smoking moves menopause forward by 1–2 years on average. Chronic high cortisol (chronic stress) appears to suppress ovarian function. Low vitamin D is associated with lower AMH in multiple cross-sectional studies, though causality isn't fully established. Alcohol accelerates follicle loss in animal models; human data is suggestive but not definitive.

• ✓Ask about AMH testing in your 30s: Your OB-GYN or a reproductive endocrinologist can order this. A low result for your age doesn't require immediate action but it does change your planning around bone density testing, cardiovascular monitoring, and HRT timing discussions.
• ✓Vitamin D optimization: Maintain 25-OH vitamin D levels above 40 ng/mL — the range associated with better ovarian reserve markers in observational data. Discuss target levels and appropriate supplementation with your doctor.
• ✓Resistance training: Weight-bearing exercise is the most evidence-backed intervention for maintaining bone density through the estrogen decline window — start building that reserve now, not after menopause.
• ✓Know your family history: Age at menopause is highly heritable. If your mother or maternal grandmother reached menopause early, your timeline may also be earlier — and your planning should reflect that.